This early-stage study is testing a new drug called TTX-MC138 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can help control the cancer. Participants will receive the drug through an…
Phase: PHASE1, PHASE2 • Sponsor: TransCode Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC